These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 16619495

  • 1. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
    Cardillo MR, Di Silverio F, Gentile V.
    Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V.
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
    Pilka R, Norata GD, Domanski H, Andersson C, Hansson S, Eriksson P, Casslén B.
    Gynecol Oncol; 2004 Sep; 94(3):661-70. PubMed ID: 15350356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.
    Jung M, Römer A, Keyszer G, Lein M, Kristiansen G, Schnorr D, Loening SA, Jung K.
    Prostate; 2003 May 01; 55(2):89-98. PubMed ID: 12661033
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H.
    Hum Pathol; 2000 Aug 01; 31(8):895-904. PubMed ID: 10987249
    [Abstract] [Full Text] [Related]

  • 14. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
    Daja MM, Niu X, Zhao Z, Brown JM, Russell PJ.
    Prostate Cancer Prostatic Dis; 2003 Aug 01; 6(1):15-26. PubMed ID: 12664060
    [Abstract] [Full Text] [Related]

  • 15. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
    Zhang L, Shi J, Feng J, Klocker H, Lee C, Zhang J.
    Prostate Cancer Prostatic Dis; 2004 Aug 01; 7(4):327-32. PubMed ID: 15356679
    [Abstract] [Full Text] [Related]

  • 16. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
    Cardillo MR, Ippoliti F.
    Anticancer Res; 2006 Aug 01; 26(5A):3409-16. PubMed ID: 17094460
    [Abstract] [Full Text] [Related]

  • 17. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
    Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR.
    Br J Cancer; 1999 Apr 01; 79(11-12):1828-35. PubMed ID: 10206300
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
    Haupt LM, Irving RE, Weinstein SR, Irving MG, Griffiths LR.
    Mol Cell Probes; 2008 Apr 01; 22(2):83-9. PubMed ID: 17669621
    [Abstract] [Full Text] [Related]

  • 19. Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
    Brehmer B, Biesterfeld S, Jakse G.
    Prostate Cancer Prostatic Dis; 2003 Apr 01; 6(3):217-22. PubMed ID: 12970724
    [Abstract] [Full Text] [Related]

  • 20. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
    Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, Risberg B, Kristensen GB, Tropé CG, Kopolovic J, Reich R.
    Am J Clin Pathol; 2001 Apr 01; 115(4):517-24. PubMed ID: 11293899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.